Abstract:
:The budding yeast Saccharomyces cerevisiae is a genetically tractable model system with which to establish the cellular target of a given agent and investigate mechanisms of drug action.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Bjornsti MAdoi
10.1016/s1535-6108(02)00160-5keywords:
subject
Has Abstractpub_date
2002-10-01 00:00:00pages
267-73issue
4eissn
1535-6108issn
1878-3686pii
S1535610802001605journal_volume
2pub_type
杂志文章,评审相关文献
CANCER CELL文献大全abstract::In this issue of Cancer Cell, Kumar et al. describe how CSF1R blockade induces not only an expected deprivation of tumor-associated macrophages, but also an accumulation of tumor-infiltrating polymorphonuclear mononuclear cells caused by Cxcl-1 released from cancer-associated fibroblasts. ...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2017.10.012
更新日期:2017-11-13 00:00:00
abstract::Rapamycin analogs that inhibit mTOR signaling have antitumor activity against certain lymphomas, but treatment of solid tumors has been less encouraging despite inhibition of mTOR function. Two recent papers give insight into the potential use of mTOR inhibitors. O'Reilly et al. provide evidence that poor tumor respon...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccr.2006.02.027
更新日期:2006-03-01 00:00:00
abstract::ERK pathway activation in cells expressing wild-type BRAF is a well-reported, clinically-relevant adverse effect of the otherwise impressive response of BRAF(V600E)-mutated melanomas to RAF inhibitors. In this issue of Cancer Cell, Holderfield and colleagues show that RAF autoinhibition underpins this paradox, further...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2013.04.021
更新日期:2013-05-13 00:00:00
abstract::Through in silico and other analyses, we identified FOXC1 as expressed in at least 20% of human AML cases, but not in normal hematopoietic populations. FOXC1 expression in AML was almost exclusively associated with expression of the HOXA/B locus. Functional experiments demonstrated that FOXC1 contributes to a block in...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2015.07.017
更新日期:2015-09-14 00:00:00
abstract::We report proteogenomic analysis of diffuse gastric cancers (GCs) in young populations. Phosphoproteome data elucidated signaling pathways associated with somatic mutations based on mutation-phosphorylation correlations. Moreover, correlations between mRNA and protein abundances provided potential oncogenes and tumor ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2018.12.003
更新日期:2019-01-14 00:00:00
abstract::Epigenetic changes are the most common alterations in human cancer, but it has been difficult to sort out cause and effect from studies of human tumors. Several recent nonlethal mouse models implicate both hypomethylation and loss of imprinting (LOI) in tumor formation, including a paper in this issue of Cancer Cell s...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2005.09.014
更新日期:2005-10-01 00:00:00
abstract::Rhabdomyosarcoma is a soft-tissue sarcoma with molecular and cellular features of developing skeletal muscle. Rhabdomyosarcoma has two major histologic subtypes, embryonal and alveolar, each with distinct clinical, molecular, and genetic features. Genomic analysis shows that embryonal tumors have more structural and c...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2013.11.002
更新日期:2013-12-09 00:00:00
abstract::In this issue of Cancer Cell, Park et al. demonstrate that anti-erbB2 antibody primes adaptive immunity for increased tumor clearance and suggest that chemotherapy may in fact interfere with this process. ...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2010.07.009
更新日期:2010-08-09 00:00:00
abstract::Myeloid-derived suppressor cells (MDSCs) play a major role in cancer. MDSC expansion is closely associated with tumor progression, but molecular mechanisms of this expansion remain poorly understood. In this issue of Cancer Cell, Strauss and colleagues describe the roles of the nuclear receptor ROR1C in the regulation...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2015.07.007
更新日期:2015-08-10 00:00:00
abstract::In a recent study, Leucci et al. report a role for the long non-coding RNA SAMMSON in driving mitochondrial function in melanoma. Targeting SAMMSON, the gene of which is frequently co-amplified with MITF, highlights a new cell-type-specific therapeutic vulnerability in melanoma irrespective of BRAF, NRAS, or p53 statu...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2016.04.010
更新日期:2016-05-09 00:00:00
abstract::The link between GBM molecular subtype and response to treatment remains undefined. In this issue of Cancer Cell, Cosset and colleagues define a subpopulation of patients within the proneural/classical subtype sensitive to integrin blockade because of a Glut3 addiction. These findings reveal context-dependent druggabl...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2017.11.017
更新日期:2017-12-11 00:00:00
abstract::Cancer genome sequencing efforts have revealed the novel theme that chromatin modifiers are frequently mutated across a wide spectrum of cancers. Mutations in genes encoding subunits of SWI/SNF (BAF) chromatin remodeling complexes are particularly prevalent, occurring in 20% of all human cancers. As these are typicall...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccr.2014.07.018
更新日期:2014-09-08 00:00:00
abstract::Activating mutations in BRAF are the most common genetic alterations in melanoma. Inhibition of BRAF by small molecules leads to cell-cycle arrest and apoptosis. We show here that BRAF inhibition also induces an oxidative phosphorylation gene program, mitochondrial biogenesis, and the increased expression of the mitoc...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2013.02.003
更新日期:2013-03-18 00:00:00
abstract::In this issue of Cancer Cell, Wieland et al. uncover a feedback loop in which tumor cells, by augmenting Notch signaling, provoke a senescent and pro-inflammatory state in endothelial cells, promoting neutrophil infiltration, tumor cell adhesion, and metastasis. Interfering with this Notch-dependent crosstalk may be a...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2017.02.016
更新日期:2017-03-13 00:00:00
abstract::Here, we show that tumor ADORA1 deletion suppresses cell growth in human melanoma cell lines in vitro and tumor development in vivo in immune-deficient xenografts. However, this deletion induces the upregulation of PD-L1 levels, which inactivates cocultured T cells in vitro, compromises anti-tumor immunity in vivo, an...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2020.02.006
更新日期:2020-03-16 00:00:00
abstract::In this issue of Cancer Cell, demonstrate a novel mechanism for the oncogenic activity of MLL chimeric proteins. By providing coiled-coil or other dimerization domains, the cytoplasmic partners of MLL fusion proteins donate a platform for MLL homodimerization, allowing recruitment of accessory factors needed to activa...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/s1535-6108(03)00192-2
更新日期:2003-08-01 00:00:00
abstract::Abnormal activation of the epidermal growth factor receptor (EGFR) and its homolog HER2 (Neu/ErbB2) has been associated with many human cancers, and monoclonal antibodies targeting EGFR and HER2 are effective anticancer therapies. Structural studies of these receptors and antibodies have revealed much about how they f...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2008.03.010
更新日期:2008-04-01 00:00:00
abstract::Single-cell sequencing (SCS) has impacted many areas of cancer research and improved our understanding of intratumor heterogeneity, the tumor microenvironment, metastasis, and therapeutic resistance. The development and refinement of SCS technologies has led to massive reductions in costs, increased cell throughput, a...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccell.2020.03.008
更新日期:2020-04-13 00:00:00
abstract::PML/RARalpha is of crucial importance in acute promyelocytic leukemia (APL) both pathologically and therapeutically. Using a genome-wide approach, we identified in vivo PML/RARalpha binding sites in a PML/RARalpha-inducible cell model. Of the 2979 targeted regions, >62% contained canonical PU.1 motifs and >84% of thes...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2009.12.045
更新日期:2010-02-17 00:00:00
abstract::The TIGAR protein has antioxidant activity that supports intestinal tissue repair and adenoma development. Using a pancreatic ductal adenocarcinoma (PDAC) model, we show that reactive oxygen species (ROS) regulation by TIGAR supports premalignant tumor initiation while restricting metastasis. Increased ROS in PDAC cel...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2019.12.012
更新日期:2020-02-10 00:00:00
abstract::Agonistic antibodies specific for members of the tumor necrosis factor receptor protein family hold great promise for immunotherapy of cancer. In this issue of Cancer Cell, White and colleagues provide evidence that the human IgG2 subclass may represent a superior backbone for the use of these antibodies in human ther...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2014.12.010
更新日期:2015-01-12 00:00:00
abstract::The erythroleukemia developed by spi-1/PU.1 transgenic mice is a multistage process characterized by an early arrest of the proerythroblast differentiation followed later on by malignant transformation. Herein, we report the presence of acquired mutations in the SCF receptor gene (Kit) in 86% of tumors isolated during...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2005.11.009
更新日期:2005-12-01 00:00:00
abstract::Neuro-glial activation is a recently identified hallmark of growing cancers. Targeting tumor hyperinnervation in preclinical and small clinical trials has yielded promising antitumor effects, highlighting the need of systematic analysis of neural influences in cancer (NIC). Here, we outline the strategies translating ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2020.05.023
更新日期:2020-07-13 00:00:00
abstract::Stress has long been suspected to negatively influence cancer mortality, yet the molecular mechanisms responsible for this effect have only recently been identified. A new study identifies a stress-induced response in dendritic cells-the activation of the glucocorticoid-inducible transcriptional regulator TSC22D3-as a...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccell.2019.10.013
更新日期:2019-11-11 00:00:00
abstract::Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms. Here we identify SMO mutations in 50% (22 of 44) of resistant BCCs and show that these mutations maintain Hedgehog signaling in the presence of SMO inhibitors. Alterations include four ligand ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2015.02.002
更新日期:2015-03-09 00:00:00
abstract::Somatic loss-of-function mutations in the ten-eleven translocation 2 (TET2) gene occur in a significant proportion of patients with myeloid malignancies. Although there are extensive genetic data implicating TET2 mutations in myeloid transformation, the consequences of Tet2 loss in hematopoietic development have not b...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2011.06.001
更新日期:2011-07-12 00:00:00
abstract::A fundamental property of cancer cells is the preferential utilization of glycolysis over aerobic respiration to produce ATP. Renewed interest in understanding the mechanism underlying this metabolic shift in energy production is broadening our understanding of the relationship between cancer and cellular metabolism. ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2006.06.014
更新日期:2006-07-01 00:00:00
abstract::The TFAP2C/AP-2γ transcription factor regulates luminal breast cancer genes, and loss of TFAP2C induces epithelial-mesenchymal transition. By contrast, the highly homologous family member, TFAP2A, lacks transcriptional activity at luminal gene promoters. A detailed structure-function analysis identified that sumoylati...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2014.04.008
更新日期:2014-06-16 00:00:00
abstract::Activating mutations in GNAQ/GNA11, encoding Gαq G proteins, are initiating oncogenic events in uveal melanoma (UM). However, there are no effective therapies for UM. Using an integrated bioinformatics pipeline, we found that PTK2, encoding focal adhesion kinase (FAK), represents a candidate synthetic lethal gene with...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2019.01.009
更新日期:2019-03-18 00:00:00
abstract::Therapeutic resistance is a major challenge in cancer treatment. In this issue of Cancer Cell, Kurppa et al. demonstrated that a senescence-like state enables lung cancer cells to survive dual inhibition of EGFR and MEK. This was mediated by the YAP/TEAD pathway, which drives epigenomic reprogramming and EMT to counte...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2019.12.008
更新日期:2020-01-13 00:00:00